Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Transcenta Holding Limited (Stock Code: 6628.HK) Announce 2024 Interim Results 2024-08-29 14:31
111, Inc. Announces Second Quarter 2024 Unaudited Financial Results 2024-08-29 14:00
Akeso's 2024 First Half Interim Results: Expanding Global Lead in IO Bispecific Antibodies, Advancing New Therapies, and Accelerating Commercialization 2024-08-29 04:20
Jenscare, with innovative TTVR, releases 2024H1 interim results 2024-08-28 21:00
Bloomage Showcases Key Bioactive Substances at CPHI and HI Korea 2024-08-28 21:00
Sasakawa Leprosy Initiative Collaborates with Miss Supranational 2024 for Leprosy Awareness Campaign in South Sulawesi, Indonesia 2024-08-28 19:00
Tigermed Reports 2024 Interim Results 2024-08-28 18:26
Fosun Pharma Announces 2024 Interim Results 2024-08-28 18:10
Harbour BioMed Announces 2024 Interim Results 2024-08-28 17:44
Hyundai Bioscience to conduct phase 3 clinical trial for high-risk group of COVID-19 patients with the goal of emergency use authorization 2024-08-28 17:29
Achieva Medical Entered into an Exclusive Distribution Agreement with NowYon Medical 2024-08-28 16:40
Laifen to Launch World's First Titanium Electric Toothbrush at IFA 2024 2024-08-28 14:00
Yunovia Announces IND Approval by the MFDS to Initiate Phase 1 MAD Study for the Small Molecule GLP-1 Agonist 2024-08-28 10:43
GenScript Subsidiary Legend Biotech Achieves Breakthrough with Cilta-cel Approval in China, Offering New Hope for Multiple Myeloma Patients 2024-08-27 22:28
Keymed Biosciences Announces Interim Results for First Half of 2024 2024-08-27 21:10
Sleep Specialists and Industry Leaders Converge at HoneyNaps Symposium 2024-08-27 21:00
111, Inc. to Participate in Fireside Chat with Water Tower Research on September 5, 2024 2024-08-27 20:00
YolTech Announces Licensing Agreement with Salubris for the Development and Commercialization of YOLT-101 in Mainland China 2024-08-27 18:30
HKBU research identifies potential of phosphocholine in counteracting PM2.5 toxicity in lung diseases 2024-08-27 13:28
Mabwell Announces CDE Approval to Initiate Phase III Clinical Trial of 9MW2821 for Urothelial Carcinoma in Combination with PD-1 Inhibitor 2024-08-26 22:00
1 24 25 26 27 28 808